首页|肠道菌群代谢产物对脑卒中后神经康复的影响及其机制研究

肠道菌群代谢产物对脑卒中后神经康复的影响及其机制研究

Effect of Intestinal Flora Metabolites on Neurological Rehabilitation after Stroke

扫码查看
目的:探讨肠道菌群代谢产物对脑卒中后神经康复的影响及其机制.方法:于 2021年 5 月—2022 年 6 月在湖南中医药大学第一附属医院神经内科连续招募 132例急性缺血性脑卒中病人.使用 16S核糖体 RNA(rRNA)基因(V3-V4 区)测序分析病人入院后 24h内的肠道微生物组.根据 3个月改良 Rankin量表(mRS)评分,将病人分为预后良好组(mRS评分 0~2 分,105 例)和预后不良组(mRS评分 3~6分,27例).从每份粪便样品分离 0.2 g,通过气相色谱/质谱分析总短链脂肪酸(SCFAs)、乙酸盐、丙酸盐和丁酸盐含量.结果:与预后良好组相比,预后不良组病人年龄更大,高血压和心房颤动的发生率更高,基线美国国立卫生研究院卒中量表(NIHSS)评分更高,扩散加权成像的 Alberta卒中项目早期 CT评分(DWI-ASPECTS)评分更低(P<0.05).预后不良组观察到的物种和 Chao1低于预后良好组(P<0.05).与预后良好组比较,预后不良组 6 个产生 SCFAs的属(拟杆菌属、粪肠杆菌属、罗氏菌属、瘤胃球菌属、粪球菌属和丁酸球菌属)的丰度均明显降低(P<0.05).预后不良组总 SCFAs、乙酸盐、丙酸盐和丁酸盐的中值浓度分别为 95.89、64.66、16.72和 10.14 μmol/g,而预后良好组的中值浓度分别为 119.30、82.05、20.89和 14.16 μmol/g,两组相比差异有统计学意义(U值分别为 3 501,3 509,3 877,4 407,P均<0.000 1).多变量分析结果显示,总 SCFAs[OR=12.44,95%CI(1.50,103.07)]和丁酸盐[OR=59.72,95%CI(2.67,1 332.15)]是脑卒中病人 90d不良功能的独立危险因素(P<0.05).结论:总 SCFAs水平降低,尤其是丁酸盐水平,与急性缺血性脑卒中病人 90d不良功能结局风险增加相关,表明 SCFAs可能是识别不良预后的有用生物标志物.
Objective:To explore the effect of intestinal flora metabolites on neurological rehabilitation after stroke and its mechanism.Methods:From May 2021 to June 2022,132 patients with acute ischemic stroke were recruited continuously.16S ribosomal RNA(rRNA)gene(V3-V4 region)was used to analyze their intestinal microbiota within 24 hours after admission.According to the 3-month mRS score,participants were divided into two groups:better functional group(n=105,mRS 0-2)and poor functional group(n=27,mRS 3-6).0.2 g was separated from each fecal sample,and the contents of total short-chain fatty acids(SCFAs),acetate,propionate,and butyrate were analyzed by gas chromatography/mass spectrometry.Results:Compared with the group with better prognosis,the patients with poor prognosis were older,with higher incidence of hypertension and atrial fibrillation,higher baseline National Institutes of Health Stroke Scale(NIHSS)score and lower the Alberta Stroke Programme Early CT Score applied to diffusion weighted imaging(DWI-ASPECTS)score(P<0.05).The observed species and Chao1 in the poor prognosis group were lower than those in the better prognosis group(P<0.05).Compared with the group with better prognosis,the abundance of six genera(Bacteroides,Enterobacter faecalis,Roche,Ruminococcus,Enterococcus faecalis,and Butyrococcus)producing SCFAs was lower,and all of them reduced significantly in the group with poor prognosis(P<0.05).The median concentrations of total SCFAs,acetate,propionate,and butyrate in patients with poor prognosis were 95.89,64.66,16.72,and 10.14μmol/g,respectively,while those in patients with good prognosis were 119.30,82.05,20.89,and 14.16μmol/g,respectively,and the difference between the two groups was statistically significant,the U values were 3 501,3 509,3 877,and 4 407,respectively(P<0.000 1).Multivariate analysis showed that total SCFAs(OR=12.44,95%CI 1.50-103.07)and butyrate(OR=59.72,95%CI 2.67-1 332.15)were independent risk factors for 90-day dysfunction in stroke patients(P<0.05).Conclusion:The decrease of total SCFAs level,especially butyrate level,is related to the increased risk of 90-day adverse functional outcome in patients with acute ischemic stroke,indicating that SCFAs may be a useful biomarker to identify adverse prognosis.

acute ischemic strokeintestinal floraprognosisneurological rehabilitation

李文雅、李春辉、肖纯、刘文娟、彭晓玲

展开 >

湖南中医药大学第一附属医院(长沙 410000)

湖南省肿瘤医院(长沙 410000)

脑卒中 肠道菌群 预后 神经康复

湖南省卫健委科研计划项目

202201322612

2024

中西医结合心脑血管病杂志
中国中西医结合学会 山西医科大学第一医院

中西医结合心脑血管病杂志

CSTPCD
影响因子:1.463
ISSN:1672-1349
年,卷(期):2024.22(20)